- United States
- /
- Biotech
- /
- NasdaqCM:AQB
AquaBounty Technologies Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AquaBounty Technologies (NASDAQ:AQB) Second Quarter 2024 Results
Key Financial Results
- Net loss: US$50.5m (loss widened by US$44.0m from 2Q 2023).
- US$13.09 loss per share (further deteriorated from US$1.83 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
AquaBounty Technologies Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 80%. Earnings per share (EPS) missed analyst estimates significantly.
Looking ahead, revenue is expected to decline by 65% p.a. on average during the next 2 years, while revenues in the Biotechs industry in the US are expected to grow by 18%.
Performance of the American Biotechs industry.
The company's shares are down 15% from a week ago.
Risk Analysis
We should say that we've discovered 5 warning signs for AquaBounty Technologies (2 are potentially serious!) that you should be aware of before investing here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqCM:AQB
AquaBounty Technologies
A biotechnology company, operates in the aquaculture industry in the United States and Canada.
Moderate with adequate balance sheet.
